Home-based Transcranial Stimulation in the Treatment of Patients With Refractory Chronic Pain
Chronic Pain
About this trial
This is an interventional treatment trial for Chronic Pain focused on measuring Transcranial electrical stimulation, Fibromyalgia, Arthritis, Arthrosis, Low back pain, Migraine headaches, Anxiety disorders, Depression, Chronic fatigue, Sleep disorders, Pain assessment, EEG
Eligibility Criteria
Inclusion Criteria:
- Suffering a chronic pain condition of non-cancer nature. Those patients who report chronic pain even after overcoming an oncological process are suitable to participate, but only if they have received the definitive medical discharge and have been free from radiotherapy/chemotherapy for at least twelve months.
- Adult subjects (18-65 years old).
- Subjects able to provide informed consent to participate in the study and to self-report pain.
- Existing chronic pain which reaches an intensity of at least 4 on a 0-10 Numeric Rating Scale (NRS) on average over the past 3 months prior to enrolment.
- Pain intensity of at least 5 on a 0-10 NRS over the week prior to enrolment.
- Diagnosis of pharmaco-resistance to analgesic drugs across the WHO ladder.
- Pharmacological regimen have kept stable for at least two months previous to the enrolment, and it must not suffer modifications during the whole research period.
Exclusion Criteria:
- Chronic pain derived from current cancer disease.
- Pregnant women or women in fertile age not having efficacious contraception during the whole period of the study.
- History of alcohol or drug abuse within the past 6 months as self-reported.
- Suffering from unstable medical conditions (e.g., uncontrolled diabetes, uncompensated cardiac issues, heart failure or chronic obstructive pulmonary disease).
- Intracranial ferromagnetic devices or implanted stimulator (basal ganglia stimulator, vagus nerve stimulation).
- Antecedents of, or active epilepsy.
- History of neurosurgery, psychiatric diseases other than anxiety or depression, traumatic brain injury with loss of consciousness, and/or cortical lesions.
Sites / Locations
- University of Santiago de CompostelaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Placebo Comparator
Transcranial direct current stimulation (tDCS)
Transcranial alternant current stimulation (tACS)
Sham stimulation
Fifteen stimulation sessions applied with a daily frequency during an uninterrupted period of time which comprises just over two weeks. Current intensity of 2mA is applied during 20 minutes at the left M1, with anodal electrode placed in C3 and cathodal in FP2, following the International 10-20 EEG System. Ramp-up and ramp-down comprises 15 seconds at the beginning and end of the stimulation period.
Fifteen stimulation sessions applied with a daily frequency during an uninterrupted period of time which comprises just over two weeks. Two electrodes will be placed at F3 and F4 and connected together for 10-Hz tACS (or the frequency which shows best sensitivity or specificity), and one electrode at Pz will be the return electrode. This setting is used to stimulate the somatosensory cortical region. Stimulation will last for 20 minutes, with a ramp-up and ramp-down of 15 seconds at the beginning and end of the session.
The electrode montage will be either the tDCS (for half of the participants) or the tACS montage (for the other half), and we will just apply the current at the ramps terms, but no current in the interval between the ramps which practically comprises the whole session. As for the two other group, fifteen sham stimulation sessions will be daily scheduled in a non-interrupted period of two weeks.